Sec. 3.5. (a) This section does not apply to a protocol adopted in a hospital.
(b) Upon authorization of a physician or physician group practice that has adopted a protocol under this chapter, the following apply:
(1) The physician shall signify in writing or by means of electronic transmission whether the protocol applies in the care and treatment of the patient or a group of patients, at the discretion of the physician or physician group practice.
(2) A pharmacist may adjust the drug therapy regimen of the patient or group of patients under the authorization of the physician, including issuing new prescriptions in writing, by electronic transmission, or by other means allowed by law.
(3) The pharmacist shall review the appropriate medical records of the patient to determine whether the physician has authorized the use of a specific protocol before adjusting the patient's drug therapy regimen.
(c) The physician or physician group practice that has adopted a protocol under this chapter:
(1) shall take appropriate actions to assure that the pharmacist has the appropriate training to administer the protocol; and
(2) may at any time modify or cancel a protocol by entering the modification or cancellation in the patient's medical record.
(d) A physician group practice that has adopted a protocol under this chapter shall designate a physician administrator who may adopt a protocol on behalf of the physician group practice for authorization by individual physicians.
As added by P.L.197-2011, SEC.112. Amended by P.L.202-2017, SEC.15.
Structure Indiana Code
Title 25. Professions and Occupations
Article 26. Pharmacists, Pharmacies, Drug Stores
25-26-16-1.5. "Therapeutic Alternative"
25-26-16-3. Protocol Upon Hospital Admission
25-26-16-3.5. Physician Protocol Application
25-26-16-4. Minimum Protocol Requirements
25-26-16-4.5. Protocol for Pharmacists
25-26-16-5. Implementation, Revision, or Renewal of Protocol
25-26-16-6. Modification of Written Protocol
25-26-16-9. Confidentiality; Liability
25-26-16-10. Substitution of Therapeutic Alternative Authorization Validity
25-26-16-11. Prohibition on Substituting a Therapeutic Alternative